Moderna

Bio & Pharma Moderna signs mRNA access deals with S.Korea's universities

The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...

Bio & Pharma Moderna to stay ahead in mRNA technology: CSO Melissa Moore

CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...

COVID-19 Korea approves export of Samsung Biologics-made Moderna vaccine

South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...

Business & Politics Jay Y. Lee meets Verizon CEO and Moderna co-founder

Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...

COVID-19 Samsung Biologics-made Moderna vaccine available to Koreans this week

Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...

COVID-19 Korean govt to spend $1.9 billion to become world’s leading vaccine maker

The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...

COVID-19 COVID treatment deals drive Samsung Bio’s record quarterly earnings

South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...

COVID-19 Samsung Biologics to make Moderna’s mRNA vaccine from Q3

Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...

Biopharma CMO Moderna deal shows Korea’s prowess as global hub for biopharma CMO

South Korea is emerging as a global hub for the contract manufacturing of biopharmaceuticals following its latest deal to procure COVID-19 vaccines ...